20,000 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Acquired by Hudson Bay Capital Management LP
Hudson Bay Capital Management LP acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 20,000 shares of the company’s stock, valued at approximately $937,000. A number of other hedge funds have also bought […]